Table 2.
Baseline characteristics of long-term survivors and nonsurvivors
| Survivors (n = 413) | Nonsurvivors (n = 182) | P Value of Difference | |
|---|---|---|---|
| Patient characteristics | |||
| Age: mean (range) | 60.9 (15 to 96) | 68.7 (27 to 93) | <0.001 |
| Male sex (%) | 61.2 | 70.2 | 0.036 |
| BMI: mean (±SD) | 26.5 (5.6) | 25.9 (4.3) | 0.253 |
| Severity scores | |||
| SHARF score 0 h: mean (±SD) | 50.8 (26.7) | 51.9 (27.2) | 0.658 |
| APACHE II 0 h: mean (±SD) | 21.1 (9.1) | 20.8 (8.1) | 0.779 |
| SOFA 0 h: mean (±SD) | 7.8 (3.4) | 7.6 (3.5) | 0.414 |
| Treatment (%) | 0.980 | ||
| Conservative | 57.1 | 57.1 | |
| IRRT | 28.6 | 28.0 | |
| CRRT | 14.3 | 14.8 | |
| ICU and hospital stay | |||
| Days ICU: mean (range) | 13.4 (1 to 106) | 13.6 (1 to 88) | 0.909 |
| Days hospitalization: mean (range) | 41.5 (1 to 339) | 45.6 (1 to 272) | 0.285 |
| Renal outcome | |||
| Creatinine clearance at discharge: mean (±SD) ml/min | 63.0 (31.3) | 55.7 (31.1) | 0.030a |
| NKF K/DOQI categories at discharge: (%) | 0.049a | ||
| >60 ml/min | 41.5 | 32.0 | |
| 30 to 60 ml/min | 34.7 | 34.7 | |
| <30 ml/min | 23.8 | 33.3 | |
| ESRD at discharge (%) | 11.9 | 15.9 | 0.175 |
RRT, renal replacement therapy; IRRT, intermittent renal replacement therapy; ICU, intensive care unit.
a
Binary logistic regression detected only age and gender as independent predictors of long-term mortality.